These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9667769)

  • 21. 6-Chloro-3-(((1-[11C]methyl)-2-(S)-pyrrolidinyl)methoxy)-5-(2-fluoropyridin-4-yl)pyridine ([11C]JHU85270), a potent ligand for nicotinic acetylcholine receptor imaging by positron emission tomography.
    Gao Y; Ravert HT; Holt D; Dannals RF; Horti AG
    Appl Radiat Isot; 2007 Aug; 65(8):947-51. PubMed ID: 17566748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.
    Nordberg A; Hartvig P; Lundqvist H; Antoni G; Ulin J; Långström B
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):195-205. PubMed ID: 2789067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380.
    Valette H; Bottlaender M; Dollé F; Guenther I; Fuseau C; Coulon C; Ottaviani M; Crouzel C
    J Nucl Med; 1999 Aug; 40(8):1374-80. PubMed ID: 10450691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Suto CM; Vernier JM
    Brain Res; 2003 Aug; 981(1-2):85-98. PubMed ID: 12885429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
    Brown L; Chefer S; Pavlova O; Vaupel DB; Koren AO; Kimes AS; Horti AG; Mukhin AG
    J Neurochem; 2004 Nov; 91(3):600-12. PubMed ID: 15485491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y; Saito K; Imoto M; Ohno T
    Eur J Pharmacol; 1998 Jun; 351(2):181-8. PubMed ID: 9687001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [125/123I] 5-Iodo-3-pyridyl ethers. syntheses and binding to neuronal nicotinic acetylcholine receptors.
    Fan H; Scheffel UA; Rauseo P; Xiao Y; Dogan AS; Yokoi F; Hilton J; Kellar KJ; Wong DF; Musachio JL
    Nucl Med Biol; 2001 Nov; 28(8):911-21. PubMed ID: 11711310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors.
    Roger G; Dollé F; De Bruin B; Liu X; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Bottlaender M; Valette H; Kassiou M
    Bioorg Med Chem; 2004 Jun; 12(12):3229-37. PubMed ID: 15158791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography.
    Chefer SI; Horti AG; Lee KS; Koren AO; Jones DW; Gorey JG; Links JM; Mukhin AG; Weinberger DR; London ED
    Life Sci; 1998; 63(25):PL355-60. PubMed ID: 9870715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
    Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
    J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
    Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
    Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.
    Villemagne VL; Horti A; Scheffel U; Ravert HT; Finley P; Clough DJ; London ED; Wagner HN; Dannals RF
    J Nucl Med; 1997 Nov; 38(11):1737-41. PubMed ID: 9374343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evaluation of [11C]-3-[2-[(3-methoxyphenylamino)carbonyl]ethenyl]-4,6-dichloroindole-2-carboxylic acid ([11C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel.
    Waterhouse RN; Sultana A; Laruelle M
    Nucl Med Biol; 2002 Nov; 29(8):791-4. PubMed ID: 12453587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.
    Nybäck H; Halldin C; Ahlin A; Curvall M; Eriksson L
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):31-6. PubMed ID: 7862909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.